Company / Current Assets
Corbus Pharmaceuticals Holdings, Inc. Current Assets History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$60.2M
FY2022
5-year range
$38.2M / $100.2M
FY2018-FY2022
Trend
-39.9%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 8 years, ranging from $13M in FY2015 to $100M in FY2021.
Based on SEC 10-K filings.
$60M in FY2022 with a 5-year CAGR of -1.7%.
Declined from $92M to $60M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +16.4%
- 5-Year CAGR
- -1.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -1.7%, indicating a declining trend.
- In FY2022, current assets decreased 39.9% year-over-year.
- Peak current assets was recorded in FY2021.
- Lowest current assets in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $60.2M | -39.9% |
| FY2021 | $100.2M | +8.8% |
| FY2020 | $92.1M | +141.3% |
| FY2019 | $38.2M | -13.8% |
| FY2018 | $44.2M | -32.5% |
| FY2017 | $65.5M | +276.4% |
| FY2016 | $17.4M | +36.9% |
| FY2015 | $12.7M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026